DuPont Pharmaceuticals
Pharmaceutical ManufacturingUnited States51-200 Employees
.
Sustainability Leadership DuPont Pharmaceuticals is actively recognized for its innovations in sustainability, notably with the Cyrel ReNew technology and energy-efficient workflows. This focus presents opportunities for clients seeking eco-friendly manufacturing solutions and sustainability-oriented partnerships.
Water Contamination Concerns Recent issues involving alleged PFOA and PFOS contamination highlight the company's potential need for advanced water treatment and environmental compliance solutions. This situation creates openings for environmental services or remediation technology providers.
Product Innovation Pipeline DuPont's launch of novel product platforms like Liveo Pharma OMAs and AmberChrom XT SL indicates ongoing innovation in biopharmaceutical and chromatography sectors. These developments suggest opportunities to provide complementary bioprocessing equipment, materials, or technical support.
Recognition & Awards Receiving prestigious awards such as the Edison Awards and energy efficiency certifications signals strong R&D capabilities and a commitment to high-performance solutions. Engaging with them as a technology or service partner could enhance joint innovation efforts or product development.
Market Position & Growth With established presence in pharmaceutical manufacturing and a revenue range of $100M to $250M, DuPont presents opportunities for scaling collaborations, especially in sustainability, environmental management, and specialized manufacturing services within their expanding product portfolio.
DuPont Pharmaceuticals uses 8 technology products and services including MATLAB, Crazy Egg, Micro Focus, and more. Explore DuPont Pharmaceuticals's tech stack below.
| DuPont Pharmaceuticals Email Formats | Percentage |
| First.Last@dupont.com | 89% |
| First.L@dupont.com | 5% |
| FLast@dupont.com | 4% |
| FirstLast@dupont.com | 2% |
DuPont Pharmaceuticals's revenue is estimated to be in the range of $100M$250M
DuPont Pharmaceuticals's revenue is estimated to be in the range of $100M$250M